seraprognostics.com (SERA): Price-to-Revenue Coefficient

Symbol and logo of brand seraprognostics.com (SERA)

Sera Prognostics (SERA) leverages scalable software and a unique biomarker algorithm to ensure high test margins. The GURU.Markets system provides the current price-to-sales ratio, where the status is 767.60, illustrating the market valuation. Proteomic analysis enables the early detection of preterm birth risks, while a streamlined express delivery network for biological samples to laboratories guarantees diagnostic speed and accuracy.

SERA Sera Prognostics Inc. Price-to-Revenue Ratio (07/04/2022 - 11/13/2026)

Sera Prognostics (SERA) - metric breakdowns and financial figures

- stock price and consensus target price:
Share Price Sera Prognostics Inc.|SERA - Price Target Chart
- stock exchange capitalization data:
Market Capitalization Sera Prognostics|SERA - Enterprise Value
- company book value details:
Net Asset Value per Share Sera Prognostics|SERA - Company Book Value|Market Value to Book Value seraprognostics.com|SERA - Company Total Assets
- debt obligations and liquidity statistics:
Total Debt to Capital Sera Prognostics|SERA - Long-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital seraprognostics.com|SERA - Company Debts|Debts to Book Capitalization Ratio Sera Prognostics|SERA - Company Long-Term Debt|Company Short-Term Loans and Borrowings Sera Prognostics|Immediate Liquidity seraprognostics.com
- earnings and multiples data:
SERA - Net Profit|Projected Net Profit Sera Prognostics|SERA - Price to Earnings Ratio|Price to Future Earnings Ratio Sera Prognostics Inc.|SERA - Price/Earnings to Growth Ratio|Company Value to EBITDA Sera Prognostics|SERA - Profit before payment of interest, taxes and amortization|Net earnings per share for the last four quarters Sera Prognostics|SERA - Net earnings per share for the last 12 months|Year-over-year earnings per share growth rate for the last twelve months seraprognostics.com|SERA - Earnings growth in current year|Consensus forecast of earnings per share growth for next year Sera Prognostics
- total revenue and sales volume data:
SERA - Revenue and Sales Volume|Company Future Sales Volume seraprognostics.com|SERA - Price-to-Revenue Ratio|Market Cap to Expected Sales Ratio Sera Prognostics
Fundamental company analysis:Sera Prognostics Inc. - SERA
Signature product of Sera Prognostics Inc.

The P/S multiple determines the market value of a business relative to its annual revenue, allowing an investor to assess the premium for future sales growth. When analyzing the revenue-based valuation of Sera Prognostics (SERA), it is important to note that the price-to-sales ratio reflects market expectations regarding the commercial implementation of their innovative proteomic tests for diagnosing preterm birth risks.

Competitors of Sera Prognostics

natera.com - Market Cap to Revenue Ratio|Price-to-Revenue Ratio Humacyte HUMA